Top Markets
Coin of the day
PT Indofarma Tbk PT Indofarma Tbk

PT Indofarma Tbk

INAF
Rank in Stocks #29054
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Share Price
$0.00748841
Last synced: 2024-07-01
Market Cap
$23.21M
Change (1 day)
-2.83%
Change (1 year)
0.00%
Country
ID
Trade PT Indofarma Tbk (INAF)

Category

P/S ratio for PT Indofarma Tbk (INAF)
P/S ratio as of 2026 TTM: 0
According to PT Indofarma Tbk latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for PT Indofarma Tbk from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors